Earnings calls

Akums Drugs concall ledger

Every earnings call for AKUMS — management tone, guidance, KPIs and promise tracking, quarter by quarter.

AKUMS · 6 transcripts · Healthcare · latest Q4 FY26

Q4 FY26Published 18 May 2026Call held 18 May 2026

AKUMS Q4 FY26 Earnings Call Transcript & Analysis

Revenue₹4,359 cr+6% YoYAdjusted EBITDA₹522 cr+13% YoYAdjusted EBITDA Margin12%PAT₹256 cr−25% YoYPBT₹382 cr+12% YoY

Revenue (FY26) ₹4,359 cr (+6% YoY); Adjusted EBITDA (FY26) ₹522 cr (+13% YoY); Adjusted EBITDA Margin (FY26) 12%. FY26 Revenue of ₹4,359 crores, up 5.8% YoY.

Read full transcript & analysis

Q3 FY26Published 16 Feb 2026Call held 16 Feb 2026

AKUMS Q3 FY26 Earnings Call Transcript & Analysis

Operating Revenue₹1,160 cr+15% YoYEBITDA Margin12.7%+1% YoYPAT₹68 cr+2% YoY

Operating Revenue ₹1,160 cr (+15% YoY); EBITDA Margin 12.7% (+1% YoY); PAT ₹68 cr (+2% YoY). Operating revenue grew 14.8% YoY to INR 1,160 crores.

Read full transcript & analysis

Q2 FY26Published 17 Nov 2025Call held 17 Nov 2025

AKUMS Q2 FY26 Earnings Call Transcript & Analysis

Revenue₹1,018 cr−2% YoYEBITDA₹94 cr−22% YoYEBITDA Margin9.3%PAT₹43 cr−36% YoY

Revenue ₹1,018 cr (−2% YoY); EBITDA ₹94 cr (−22% YoY); EBITDA Margin 9.3%. Revenue stood at INR 1,018 crores, a decline of 1.5% YoY and 0.6% QoQ.

Read full transcript & analysis

Q1 FY26Published 11 Aug 2025Call held 11 Aug 2025

AKUMS Q1 FY26 Earnings Call Transcript & Analysis

Reported EBITDA₹156 cr+19% YoYReported EBITDA Margin14.8%+2% YoYAdjusted PAT₹65 cr+13% YoYTotal Income₹1,051 cr+2% YoY

Reported EBITDA ₹156 cr (+19% YoY); Reported EBITDA Margin 14.8% (+2% YoY); Adjusted PAT ₹65 cr (+13% YoY). Total Income at ₹1,051 crores, up 2.4% YoY.

Read full transcript & analysis

Q4 FY25Published 27 May 2025Call held 27 May 2025

AKUMS Q4 FY25 Earnings Call Transcript & Analysis

FY25 Revenue₹4,170 cr−1% YoYFY25 PAT₹234 cr+6% YoY

FY25 Revenue ₹4,170 cr (−1% YoY); FY25 PAT ₹234 cr (+6% YoY). Full year FY25 PAT increased to INR234 crores from INR220 crores last year.

Read full transcript & analysis

Q3 FY25Published 07 Feb 2025Call held 07 Feb 2025

AKUMS Q3 FY25 Earnings Call Transcript & Analysis

EBITDA₹136 cr+12% YoYPAT₹66 cr+15% YoYTotal Income₹1,025 cr−6% YoY

EBITDA ₹136 cr (+12% YoY); PAT ₹66 cr (+15% YoY); Total Income ₹1,025 cr (−6% YoY). EBITDA grew 1% QoQ to INR136 crores and 12% YoY.

Read full transcript & analysis